AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
AAPL   318.25 (+0.04%)
MSFT   181.40 (-0.23%)
FB   225.46 (-1.61%)
GOOGL   1,418.24 (-0.14%)
AMZN   2,401.10 (-0.39%)
NVDA   339.48 (-0.45%)
CGC   21.72 (+9.15%)
BABA   199.49 (-0.84%)
MU   46.47 (-6.03%)
GE   6.78 (-7.00%)
TSLA   805.81 (-1.76%)
AMD   51.74 (-1.90%)
T   31.06 (-2.48%)
ACB   15.34 (+0.26%)
F   5.85 (-2.99%)
GILD   75.32 (+0.56%)
DIS   116.75 (-3.93%)
NFLX   413.44 (-1.54%)
BAC   24.86 (-4.31%)
BA   149.82 (+0.20%)
Log in

NASDAQ:ULBIUltralife Stock Price, Forecast & News

$8.35
+0.06 (+0.72 %)
(As of 05/28/2020 04:00 PM ET)
Add
Compare
Today's Range
$8.05
Now: $8.35
$8.58
50-Day Range
$6.00
MA: $7.33
$8.48
52-Week Range
$4.85
Now: $8.35
$10.00
Volume22,700 shs
Average Volume31,643 shs
Market Capitalization$132.59 million
P/E Ratio22.57
Dividend YieldN/A
Beta1.33
Ultralife Corporation designs, manufactures, installs, and maintains power, and communication and electronic systems for government, defense, and commercial sectors worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle adapters, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. The segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. It sells its products under the Ultralife, Lithium Power, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, and ENTELLION brands through original equipment manufacturers, and industrial and defense supply distributors, as well as directly to the United States and international defense departments. In addition, the company sells its 9-volt battery to the broader consumer market through national and regional retail chains and Internet retailers. Ultralife Corporation was founded in 1990 and is headquartered in Newark, New York.
Read More
Ultralife logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 5.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.61 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous electrical machinery, equipment, & supplies
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:ULBI
CUSIPN/A
Phone315-332-7100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$106.79 million
Cash Flow$0.58 per share
Book Value$6.94 per share

Profitability

Net Income$5.20 million

Miscellaneous

EmployeesN/A
Market Cap$132.59 million
Next Earnings Date8/6/2020 (Estimated)
OptionableOptionable

Receive ULBI News and Ratings via Email

Sign-up to receive the latest news and ratings for ULBI and its competitors with MarketBeat's FREE daily newsletter.

Ultralife (NASDAQ:ULBI) Frequently Asked Questions

How has Ultralife's stock been impacted by COVID-19 (Coronavirus)?

Ultralife's stock was trading at $6.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ULBI shares have increased by 29.7% and is now trading at $8.35. View which stocks have been most impacted by Coronavirus.

When is Ultralife's next earnings date?

Ultralife is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Ultralife.

How were Ultralife's earnings last quarter?

Ultralife Corp. (NASDAQ:ULBI) announced its quarterly earnings data on Thursday, August, 2nd. The technology company reported $0.10 EPS for the quarter. The technology company earned $22.86 million during the quarter. Ultralife had a return on equity of 6.74% and a net margin of 5.13%. View Ultralife's earnings history.

How will Ultralife's stock buyback program work?

Ultralife announced that its board has initiated a share repurchase plan on Thursday, November 1st 2018, which permits the company to repurchase 2,500,000 outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's board of directors believes its shares are undervalued.

Has Ultralife been receiving favorable news coverage?

Headlines about ULBI stock have trended very negative on Thursday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Ultralife earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave news articles about the technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutUltralife.

Are investors shorting Ultralife?

Ultralife saw a drop in short interest in April. As of April 30th, there was short interest totaling 92,400 shares, a drop of 12.2% from the April 15th total of 105,200 shares. Based on an average daily volume of 35,000 shares, the days-to-cover ratio is currently 2.6 days. Approximately 0.9% of the company's shares are sold short. View Ultralife's Current Options Chain.

Who are some of Ultralife's key competitors?

What other stocks do shareholders of Ultralife own?

Who are Ultralife's key executives?

Ultralife's management team includes the following people:
  • Mr. Michael D. Popielec, CEO, Pres & Director (Age 57)
  • Mr. Philip A. Fain, CFO, Treasurer & Corp. Sec. (Age 64)

What is Ultralife's stock symbol?

Ultralife trades on the NASDAQ under the ticker symbol "ULBI."

Who are Ultralife's major shareholders?

Ultralife's stock is owned by many different institutional and retail investors. Top institutional investors include Russell Investments Group Ltd. (3.19%), THB Asset Management (3.06%), Franklin Resources Inc. (2.25%), Wellington Management Group LLP (1.65%), Teton Advisors Inc. (1.15%) and Essex Investment Management Co. LLC (1.08%). Company insiders that own Ultralife stock include Bradford T Whitmore, Philip A Fain, Thomas Louis Saeli and W Shaw Robert. View institutional ownership trends for Ultralife.

Which major investors are selling Ultralife stock?

ULBI stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Wellington Management Group LLP, THB Asset Management, Franklin Resources Inc., and Essex Investment Management Co. LLC. View insider buying and selling activity for Ultralife.

Which major investors are buying Ultralife stock?

ULBI stock was bought by a variety of institutional investors in the last quarter, including Teton Advisors Inc., and Cambridge Investment Research Advisors Inc.. Company insiders that have bought Ultralife stock in the last two years include Bradford T Whitmore, Philip A Fain, Thomas Louis Saeli, and W Shaw Robert. View insider buying and selling activity for Ultralife.

How do I buy shares of Ultralife?

Shares of ULBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Ultralife's stock price today?

One share of ULBI stock can currently be purchased for approximately $8.35.

How big of a company is Ultralife?

Ultralife has a market capitalization of $132.59 million and generates $106.79 million in revenue each year.

What is Ultralife's official website?

The official website for Ultralife is www.ultralifecorporation.com.

How can I contact Ultralife?

Ultralife's mailing address is 2000 TECHNOLOGY PARKWAY, NEWARK NY, 14513. The technology company can be reached via phone at 315-332-7100.

This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.